ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Colorectal Cancer

Prostate Cancer trials near Seattle, WA, USA:

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

Seattle, Washington, United States and 92 other locations

Recently updated

This is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate...

Active, not recruiting
Metastatic Prostate Cancer
Drug: Apalutamide
Drug: Abiraterone acetate

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Seattle, Washington, United States and 11 other locations

This Phase 2, open-label, multicenter study is conducted in patients with castration-resistant prostate cancer.Patients in this stu ...

Enrolling
Prostate Cancer (Adenocarcinoma)
Castration-Resistant Prostate Cancer
Drug: Oral MRT-2359
Drug: Apalutamide

Phase 2

Monte Rosa Therapeutics

Seattle, Washington, United States and 13 other locations

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Seattle, Washington, United States and 14 other locations

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Tacoma, Washington, United States and 25 other locations

is a multi-center, open-label Phase 1/2 trial evaluating the safety and efficacy of AB-3028 in subjects with metastatic castration resistant prostate...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Biological: AB-3028

Phase 1, Phase 2

ArsenalBio

Seattle, Washington, United States and 8 other locations

There are many treatment options for men with various stages of prostate cancer. Some treatments work well for a while but can caus ...

Enrolling
Hormone-refractory Prostate Cancer
Drug: VIR-5500
Drug: Androgen receptor signaling inhibitor (ARSI)

Phase 1

Astellas
Astellas

Seattle, Washington, United States of America and 25 other locations

The primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an...

Enrolling
Prostate Cancer
Drug: GnRH Antagonist
Drug: Xaluritamig

Phase 1

Amgen
Amgen

Seattle, Washington, United States and 8 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Active, not recruiting
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Seattle, Washington, United States and 42 other locations

This is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate...

Enrolling
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer (Adenocarcinoma)
Drug: ACE-232 tablets

Phase 1

Acerand Therapeutics (Hong Kong) Limited

Seattle, Washington, United States of America and 12 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems